GlaxoSmithKline reports rise in net profit

home   >   MSN news

LONDON -- Pharmaceutical giant GlaxoSmithKline PLC said Thursday that strong European sales growth of key drugs underpinned a 16 percent rise in quarterly net profits. ... Collins Stewart noted that sales of asthma drug Advair were keeping momentum, while sales of secondary products 'look ... Sales of Advair, also known as Seretide, rose 22 percent to 690 ...

- link to GlaxoSmithKline reports rise in net profit -
Last update: 05/26/2005

Recommended Reading

    Advair Diskus throws GSK into the forefront: GlaxoSmithKline makes effective use of robotics to produce the No. 1 asthma inhaler.(Plants of the year: ... ine) : An article from: Food & Drug Packaging
    Advair Diskus 250/50.(New & Approved) : An article from: Family Practice News
    Advair Diskus. : An article from: Family Practice News
    Advair Diskus throws GSK into the forefront: GlaxoSmithKline makes effective use of robotics to produce the No. 1 asthma inhaler.(Plants of the year: ... ine) : An article from: Food & Drug Packaging
    Advair beats combivent for patients with COPD.(Pulmonary Medicine)(chronic obstructive pulmonary disease) : An article from: Internal Medicine News
    Advair diskus 250/50.(New & Approved) : An article from: Internal Medicine News
    FDA Panel Backs Combination Steroid-Bronchodilator Inhaler.(Brief Article)(Statistical Data Included) : An article from: Family Practice News
    Advair Diskus.(New & Approved) : An article from: Pediatric News